HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,343,071 | -12.1% | 218,405 | -17.0% | 0.10% | -2.0% |
| Q2 2023 | $9,489,585 | +133858.0% | 263,088 | +41.8% | 0.10% | +30.3% |
| Q1 2023 | $7,084 | -33.4% | 185,502 | -0.7% | 0.08% | -36.1% |
| Q4 2022 | $10,631 | -99.9% | 186,854 | -2.0% | 0.12% | +32.2% |
| Q3 2022 | $7,538,000 | +2681.5% | 190,707 | +1323.2% | 0.09% | +1400.0% |
| Q4 2017 | $271,000 | +16.3% | 13,400 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $233,000 | +35.5% | 13,400 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $172,000 | -1.1% | 13,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $174,000 | -47.3% | 13,400 | -59.9% | 0.00% | -50.0% |
| Q4 2016 | $330,000 | +17.9% | 33,400 | +51.8% | 0.01% | +166.7% |
| Q1 2014 | $280,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |